Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means
Decrypt1h agoUpdated 1h ago
Smart Read
A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.
Coins in this story
Discussion
Related stories
Decrypt
Coinbase Adds 50x Crypto Perps to Base App Through Hyperliquid
The Hyperliquid integration gives eligible Base App users access to more than 290 perpetual futures markets.
Decrypt
Coinbase's Base Is Betting Big on AI Agents With $1 Million Startup Accelerator
Base is narrowing its accelerator to 10 startups as it looks for teams building AI agents, payments, trading, and financing products.
Decrypt
Morning Minute: SEC Brings Clarity to Crypto
If the proposed rules are formalized, it could lead to an ICO boom in the U.S.
KryptoKite aggregates and summarises third-party crypto news. This is informational content, not investment advice. KryptoKite does not recommend buying or selling any asset.